Laddar...
GSK3 alpha and beta are new functionally relevant targets of tivantinib in lung cancer cells
Tivantinib has been described as a potent and highly selective inhibitor of the receptor tyrosine kinase c-MET and is currently in advanced clinical development for several cancers including non-small cell lung cancer (NSCLC). However, recent studies suggest that tivantinib’s anticancer properties a...
Sparad:
| Huvudupphovsmän: | , , , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2013
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3944088/ https://ncbi.nlm.nih.gov/pubmed/24215125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cb400660a |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|